Skip over navigation
Post a Job
Submit News Release
MT BioHistory (TM)
Earn a Master's in Pharmaceutical Bioengineering part-time in the evenings at UW. Learn more.
Cadence announces strategic plan to secure long-term nanufacture and supply of OFIRMEV(R)
Cadence announced a supply agreement with Laboratorios Grifols for development, manufacture and supply of commercial quantities of OFIRMEV (acetaminophen) injection in flexible plastic bags. The company has terminated its supply agreement for OFIRMEV in glass vials with Baxter Healthcare.
March 06, 2013
Email This Page
to a Friend
© 2015 Info.Resource, Inc. All rights reserved.
MontanaLifeScience.com is owned and published by